Does addition of 13-cis-retinoic acid to interferon-alpha2a improve survival in patients with metastatic RCC?
J Atzpodien is Professor and Head of Medical Oncology at the Fachklinik Hornheide, University of Münster, Germany.
Jens
J
Atzpodien